Gate Neurosciences to share new data and research on its synaptic function molecules with multiple posters at 2024 ASCP meeting. (2024, May 15).

Gate expects to gain a more nuanced understanding of how dose levels and intervals can be optimized for enduring effects on synaptic function in patients, which further optimizes a next Phase 2 ...

Qu Biologics is a clinical stage biotechnology company developing Site Specific Immunomodulators (SSI), a novel class of immunomodulators designed to restore innate immune function in targeted ...